Sugi Predict
/ Targets
/ LSM12
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to LSM12 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control |
PHASE3 | COMPLETED |
| Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics |
PHASE3 | COMPLETED |
| A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs |
PHASE1/PHASE2 | COMPLETED |
| NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy |
PHASE2 | UNKNOWN |
| DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors |
PHASE1/PHASE2 | RECRUITING |
| Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer |
PHASE2 | COMPLETED |
| Phase 2 Study of Yimitasvir Phosphate Capsules |
PHASE2 | COMPLETED |
| Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease |
PHASE2 | COMPLETED |
| A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia |
PHASE2 | ENROLLING_BY_INVITATION |
| Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America |
PHASE1/PHASE2 | COMPLETED |
| Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care |
PHASE1/PHASE2 | COMPLETED |
| Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis |
PHASE2 | ACTIVE_NOT_RECRUITING |
| A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia |
PHASE2 | ACTIVE_NOT_RECRUITING |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer |
PHASE1 | RECRUITING |
| A Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian Adults |
PHASE1 | COMPLETED |
| Class II Invariant Chain HCV Vaccine Study |
PHASE1 | COMPLETED |
| A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 |
PHASE1 | COMPLETED |
| Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer |
PHASE1 | RECRUITING |
| Phase I Study of LNF1901 in Advanced Malignant Tumors |
PHASE1 | NOT_YET_RECRUITING |
| A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors |
PHASE1 | ENROLLING_BY_INVITATION |
| A Study of TAVO412 in Patients with Cancer |
PHASE1 | ACTIVE_NOT_RECRUITING |
| BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma |
PHASE1 | COMPLETED |
| Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma |
PHASE1 | COMPLETED |
| Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults |
PHASE1 | RECRUITING |
| MTS109 in Patients With Refractory Autoimmune Diseases |
EARLY_PHASE1 | RECRUITING |
| MEHMO Natural History and Biomarkers |
nan | RECRUITING |
| Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population |
nan | COMPLETED |
| Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis |
nan | COMPLETED |
| Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia |
nan | NOT_YET_RECRUITING |
| Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients |
nan | RECRUITING |
Related proteins — ESM-2 sequence neighbours (a LSM12 binder may also engage these)